Ophthalmology

Administrative services provider ReFocus Eye Health has partnered with Connecticut-based Greenwich Ophthalmology Associates. 

Ophthalmic medical device company Iantrek has closed a $23 million series B funding round. 

Invirsa has submitted an investigational new drug application to the FDA for INV-102, a medication intended to treat ocular conditions and dry eye caused by DNA damage. 

Garden City, N.Y.-based OCLI Vision added Himakshi Bhatt, OD, to Ophthalmic Consultants of Connecticut.

Horizon Pharmaceuticals has been sued by a man in Arizona for allegedly failing to inform regulators that its thyroid eye diseases medication, Tepezza, can cause permanent ear ringing and hearing loss, according to an Aug. 25 report from Law360. 

Since 2010, 504,000 clinical trials have started in the U.S., according to a report from Definitive Healthcare. 

Here are the top five ophthalmologists in the U.S. in 2022, according to a survey of more than 10,000 ophthalmologists conducted by Newsweek.

From New York to California, 175 optometrist and ophthalmologists have been named the best eye doctors in America for 2022 by Newsweek. 

Leon Rafailov, MD, an oculoplastic surgeon at SightMD who specializes in minimally invasive procedures, has become one of the first physicians in Long Island (N.Y.) to perform a corneal neurotization. 

The drug market is not impervious to worldwide supply chain issues, and ophthalmologists are experiencing drug shortages like most other physicians this year.